STATISTICAL ANALYSIS OF 100 BREAST CANCER CASES WITH EVALUATION OF HER2/NEU STATUS IMMUNOHISTOCHEMISTRY CORRELATION WITH GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION ASSAY

被引:0
|
作者
Sivakami [1 ]
Kannan, Indhu [1 ]
Madhusudhanan [1 ]
机构
[1] Meenakshi Mission Hosp & Res Ctr, Dept Pathol, Madurai, Tamil Nadu, India
关键词
Breast Cancer; Infiltrating Ductal Carcinoma (NOS) HER 2 Gene Immunohistochemistry Fluorescence; in Situ Hybridization;
D O I
10.14260/jemds/2018/1174
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Breast cancer has surpassed all other cancers in women becoming the leading cause for mortality. 100 breast cancer cases received in our department of pathology during the period 2016-2017 were evaluated for HER2/neu status and immunohistochemistry correlation with gene amplification by FISH assay. MATERIALS AND METHODS Mastectomy samples received were fixed followed by grossing including all parameters like laterality, size, margin status and adequate lymph node sampling. The tissue sections were stained with H&E for assessing the tumour type, grade, surgical margin clearance study. Lymph node involvement, oestrogen receptor and progesterone receptors Her2/neu was done with immunohistochemistry in the tumour blocks. Subsequently tissue blocks were also subjected to FISH evaluation for Her2/neu. RESULTS The tumour laterality, tumour categorization, staging, and grading were analysed. Comparison of immunohistochemical Her2 results with FISH was done. CONCLUSION Immunohistochemical analysis of Her2/neu with 0 and 1+ Negative. 3+ strong positive had a High concordance with FISH evaluation.
引用
收藏
页码:5298 / 5303
页数:6
相关论文
共 50 条
  • [21] Her-2/neu Oncogene Amplification by Fluorescence In Situ Hybridization and Protein Overexpression on Immunohistochemistry in Breast Cancer
    Lateef, Fouzia
    Jamal, Saba
    Nasir, Surrayya
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (08): : 581 - 585
  • [22] HER2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
    Shirsat, Hemlata S.
    Epari, Sridhar
    Shet, Tanuja
    Bagal, Rajani
    Hawaldar, Rohini
    Desai, Sangeeta B.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (02) : 175 - 179
  • [23] HER2 amplification: Correlation of chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Wixom, CR
    Albers, EA
    Weidner, N
    LABORATORY INVESTIGATION, 2003, 83 (01) : 51A - 51A
  • [24] Correlation between HER2 gene amplification and protein overexpression through fluorescence in situ hybridization and immunohistochemistry in breast carcinoma patients
    Makroo, R. N.
    Chowdhry, Mohit
    Kumar, Manoj
    Srivastava, Priyanka
    Tyagi, Richa
    Bhadauria, Preeti
    Kaul, Sumaid
    Sarin, Ramesh
    Das, P. K.
    Dua, Harsh
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (04) : 481 - 484
  • [25] Automated Silver-enhanced In Situ Hybridization for Evaluation of HER2 Gene Status in Breast Carcinoma: Comparison with Fluorescence In Situ Hybridization and Immunohistochemistry
    Sung, Woo Jung
    Park, Seok Ju
    Gu, Mi Jin
    Bae, Young Kyung
    KOREAN JOURNAL OF PATHOLOGY, 2010, 44 (01) : 28 - 34
  • [26] Changes in HER2 Amplification Status for Breast Cancer Patients After Immunohistochemistry Directed In Situ Hybridization
    Beech, Cameron
    Wilcock, Diane M.
    Moore, Kristina H.
    Rowe, Leslie
    Mahlow, Jonathan
    Jedrzkiewicz, Jolanta
    Cleary, Allison S.
    Lomo, Lesley
    Ruano, Ana L.
    Gering, Maarika
    Bradshaw, Derek
    Maughan, Meghan
    Tran, Phuong
    Davis, Richard
    Affolter, Kajsa
    Albertson, Daniel J.
    Adelhardt, Parisa
    Kim, Jongtaek
    Coleman, Joshua F.
    Deftereos, Georgios
    Gulbahce, Evin H.
    Sirohi, Deepika
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2025, 33 (02) : 91 - 102
  • [27] Correlation of Her-2/neu results by immunohistochemistry and fluorescence in situ hybridization with survival in breast cancer.
    Kakar, S
    Puangsuvan, N
    Mihalov, ML
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 114 (04) : 656 - 656
  • [28] Dual-Color In Situ Hybridization (Dual ISH) for Evaluation of HER2/Neu (HER2) Amplification in Breast Cancer
    Astvatsaturyan, K.
    Bose, S.
    MODERN PATHOLOGY, 2013, 26 : 28A - 28A
  • [29] Detection of HER-2/neu gene amplification by fluorescence in situ hybridization in human breast cancer
    Coupier, I
    Llorca, FP
    Perissel, B
    Tchirkov, A
    Malet, P
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 120 - 120
  • [30] Dual-Color In Situ Hybridization (Dual ISH) for Evaluation of HER2/Neu (HER2) Amplification in Breast Cancer
    Astvatsaturyan, K.
    Bose, S.
    LABORATORY INVESTIGATION, 2013, 93 : 28A - 28A